Correlation Between BioCardia and Neurobiological Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioCardia and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioCardia and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioCardia and Neurobiological Technologies, you can compare the effects of market volatilities on BioCardia and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioCardia with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioCardia and Neurobiological Technologies.

Diversification Opportunities for BioCardia and Neurobiological Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioCardia and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioCardia and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and BioCardia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioCardia are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of BioCardia i.e., BioCardia and Neurobiological Technologies go up and down completely randomly.

Pair Corralation between BioCardia and Neurobiological Technologies

If you would invest  2.61  in BioCardia on October 7, 2024 and sell it today you would lose (2.61) from holding BioCardia or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.2%
ValuesDaily Returns

BioCardia  vs.  Neurobiological Technologies

 Performance 
       Timeline  
BioCardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioCardia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioCardia is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Neurobiological Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

BioCardia and Neurobiological Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioCardia and Neurobiological Technologies

The main advantage of trading using opposite BioCardia and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioCardia position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.
The idea behind BioCardia and Neurobiological Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets